| Dr George Reeves Throop Iii, MD | |
|
1142 Nw Scenic Dr, Albany, OR 97321-9669 | |
| (541) 928-5279 | |
| Not Available |
| Full Name | Dr George Reeves Throop Iii |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 1142 Nw Scenic Dr, Albany, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790078608 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 09178 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr George Reeves Throop Iii, MD 1142 Nw Scenic Dr, Albany, OR 97321-9669 Ph: (541) 928-5279 | Dr George Reeves Throop Iii, MD 1142 Nw Scenic Dr, Albany, OR 97321-9669 Ph: (541) 928-5279 |
News Archive
Researchers at the Johns Hopkins Kimmel Cancer Center discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, demonstrating a possible pathway for treatment of people with pancreatic cancers whose response to standard immunotherapy is poor.
National Cancer Institute (NCI) has renewed a $11.5 million Specialized Program of Research Excellence (SPORE) grant in prevention, diagnosis and treatment of ovarian cancer, which supports multidisciplinary research at Fox Chase Cancer Center and the University of Pennsylvania. First approved in 1999, this marks the third five-year term for the Fox Chase-Penn Ovarian SPORE.
MusclePharm® Corporation, the fastest-growing brand in the sports nutrition supplement industry, announces that its common stock is now trading on the OTC Bulletin Board (OTCBB) under the ticker symbol "MSLP."
Pennington Biomedical Research Center is leading a federally funded effort to increase COVID-19 testing in Louisiana's Black communities, which have been hit hard by the virus.
Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.
› Verified 3 days ago
Richard Rosevelt Jones, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1052 29th Ave Sw, Albany, OR 97321 Phone: 541-812-5060 | |
Courtney Rosenthal, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2730 Pacific Blvd Se, Albany, OR 97321 Phone: 541-967-3866 | |
Kolby Walker, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2730 Pacific Blvd Se, Albany, OR 97321 Phone: 541-967-3866 | |
Gale A Smolen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 445 3rd Ave Sw, Albany, OR 97321 Phone: 541-967-3866 Fax: 541-928-3020 | |
Connie Shen, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 445 3rd Ave Sw, Albany, OR 97321 Phone: 541-967-3866 | |
Robert F Vandiver, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 445 3rd Ave Sw, Albany, OR 97321 Phone: 541-967-3866 Fax: 541-928-3020 | |
Dr. Allen G. Brooks, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1086 7th Ave Sw, #202, Albany, OR 97321 Phone: 541-928-2965 Fax: 541-917-3778 |